Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size 2017-2028

2.1.2 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Segment by Type

2.2.1 PCR

2.2.2 In-situ Hybridization

2.2.3 Immunohistochemistry

2.2.4 Sequencing

2.2.5 Others

2.3 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type

2.3.1 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Type (2017-2022)

2.4 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Segment by Application

2.4.1 Oncology

2.4.2 Neurological Disorders

2.4.3 Cardiovascular Disease

2.4.4 Immunological Disorders

2.4.5 Others

2.5 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application

2.5.1 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Application (2017-2022)

3 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Player

3.1 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Players

3.1.1 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue by Players (2020-2022)

3.1.2 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Market Share by Players (2020-2022)

3.2 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) by Regions

4.1 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Regions (2017-2022)

4.2 Americas Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth (2017-2022)

4.3 APAC Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth (2017-2022)

4.4 Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth (2017-2022)

4.5 Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth (2017-2022)

5 Americas

5.1 Americas Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country (2017-2022)

5.2 Americas Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017-2022)

5.3 Americas Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Region (2017-2022)

6.2 APAC Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017-2022)

6.3 APAC Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) by Country (2017-2022)

7.2 Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017-2022)

7.3 Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) by Region (2017-2022)

8.2 Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017-2022)

8.3 Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Forecast

10.1 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Forecast by Regions (2023-2028)

10.1.1 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Forecast by Regions (2023-2028)

10.1.2 Americas Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Forecast

10.1.3 APAC Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Forecast

10.1.4 Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Forecast

10.1.5 Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Forecast

10.2 Americas Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Forecast by Country (2023-2028)

10.2.1 United States Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Forecast

10.2.2 Canada Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Forecast

10.2.3 Mexico Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Forecast

10.2.4 Brazil Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Forecast

10.3 APAC Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Forecast by Region (2023-2028)

10.3.1 China Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Forecast

10.3.2 Japan Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Forecast

10.3.3 Korea Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Forecast

10.3.4 Southeast Asia Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Forecast

10.3.5 India Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Forecast

10.3.6 Australia Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Forecast

10.4 Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Forecast by Country (2023-2028)

10.4.1 Germany Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Forecast

10.4.2 France Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Forecast

10.4.3 UK Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Forecast

10.4.4 Italy Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Forecast

10.4.5 Russia Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Forecast

10.5 Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Forecast by Region (2023-2028)

10.5.1 Egypt Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Forecast

10.5.2 South Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Forecast

10.5.3 Israel Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Forecast

10.5.4 Turkey Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Forecast

10.5.5 GCC Countries Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Forecast

10.6 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Forecast by Type (2023-2028)

10.7 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Qiagen NV

11.1.1 Qiagen NV Company Information

11.1.2 Qiagen NV Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product Offered

11.1.3 Qiagen NV Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Qiagen NV Main Business Overview

11.1.5 Qiagen NV Latest Developments

11.2 GE Healthcare

11.2.1 GE Healthcare Company Information

11.2.2 GE Healthcare Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product Offered

11.2.3 GE Healthcare Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 GE Healthcare Main Business Overview

11.2.5 GE Healthcare Latest Developments

11.3 Agilent Technologies

11.3.1 Agilent Technologies Company Information

11.3.2 Agilent Technologies Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product Offered

11.3.3 Agilent Technologies Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Agilent Technologies Main Business Overview

11.3.5 Agilent Technologies Latest Developments

11.4 F Hoffman La Roche

11.4.1 F Hoffman La Roche Company Information

11.4.2 F Hoffman La Roche Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product Offered

11.4.3 F Hoffman La Roche Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 F Hoffman La Roche Main Business Overview

11.4.5 F Hoffman La Roche Latest Developments

11.5 Foundation Medicine

11.5.1 Foundation Medicine Company Information

11.5.2 Foundation Medicine Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product Offered

11.5.3 Foundation Medicine Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Foundation Medicine Main Business Overview

11.5.5 Foundation Medicine Latest Developments

11.6 Thermo Fisher Scientific Inc.

11.6.1 Thermo Fisher Scientific Inc. Company Information

11.6.2 Thermo Fisher Scientific Inc. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product Offered

11.6.3 Thermo Fisher Scientific Inc. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Thermo Fisher Scientific Inc. Main Business Overview

11.6.5 Thermo Fisher Scientific Inc. Latest Developments

11.7 Leica Biosystems Nussloch GmBH

11.7.1 Leica Biosystems Nussloch GmBH Company Information

11.7.2 Leica Biosystems Nussloch GmBH Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product Offered

11.7.3 Leica Biosystems Nussloch GmBH Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Leica Biosystems Nussloch GmBH Main Business Overview

11.7.5 Leica Biosystems Nussloch GmBH Latest Developments

11.8 Pfizer

11.8.1 Pfizer Company Information

11.8.2 Pfizer Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product Offered

11.8.3 Pfizer Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Pfizer Main Business Overview

11.8.5 Pfizer Latest Developments

12 Research Findings and Conclusion

Table 1. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of PCR

Table 3. Major Players of In-situ Hybridization

Table 4. Major Players of Immunohistochemistry

Table 5. Major Players of Sequencing

Table 6. Major Players of Others

Table 7. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017-2022) & ($ Millions)

Table 9. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Type (2017-2022)

Table 10. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 11. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017-2022) & ($ Millions)

Table 12. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Application (2017-2022)

Table 13. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue by Players (2020-2022) & ($ Millions)

Table 14. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Market Share by Player (2020-2022)

Table 15. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Key Players Head office and Products Offered

Table 16. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 17. New Products and Potential Entrants

Table 18. Mergers & Acquisitions, Expansion

Table 19. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Regions 2017-2022 & ($ Millions)

Table 20. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Regions (2017-2022)

Table 21. Americas Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country (2017-2022) & ($ Millions)

Table 22. Americas Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Country (2017-2022)

Table 23. Americas Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017-2022) & ($ Millions)

Table 24. Americas Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Type (2017-2022)

Table 25. Americas Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017-2022) & ($ Millions)

Table 26. Americas Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Application (2017-2022)

Table 27. APAC Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Region (2017-2022) & ($ Millions)

Table 28. APAC Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Region (2017-2022)

Table 29. APAC Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017-2022) & ($ Millions)

Table 30. APAC Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Type (2017-2022)

Table 31. APAC Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017-2022) & ($ Millions)

Table 32. APAC Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Application (2017-2022)

Table 33. Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country (2017-2022) & ($ Millions)

Table 34. Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Country (2017-2022)

Table 35. Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017-2022) & ($ Millions)

Table 36. Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Type (2017-2022)

Table 37. Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017-2022) & ($ Millions)

Table 38. Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Application (2017-2022)

Table 39. Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Region (2017-2022) & ($ Millions)

Table 40. Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Region (2017-2022)

Table 41. Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Type (2017-2022)

Table 43. Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017-2022) & ($ Millions)

Table 44. Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Application (2017-2022)

Table 45. Key Market Drivers & Growth Opportunities of Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx)

Table 46. Key Market Challenges & Risks of Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx)

Table 47. Key Industry Trends of Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx)

Table 48. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 49. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share Forecast by Regions (2023-2028)

Table 50. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 51. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share Forecast by Type (2023-2028)

Table 52. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 53. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share Forecast by Application (2023-2028)

Table 54. Qiagen NV Details, Company Type, Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Area Served and Its Competitors

Table 55. Qiagen NV Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product Offered

Table 56. Qiagen NV Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 57. Qiagen NV Main Business

Table 58. Qiagen NV Latest Developments

Table 59. GE Healthcare Details, Company Type, Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Area Served and Its Competitors

Table 60. GE Healthcare Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product Offered

Table 61. GE Healthcare Main Business

Table 62. GE Healthcare Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 63. GE Healthcare Latest Developments

Table 64. Agilent Technologies Details, Company Type, Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Area Served and Its Competitors

Table 65. Agilent Technologies Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product Offered

Table 66. Agilent Technologies Main Business

Table 67. Agilent Technologies Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 68. Agilent Technologies Latest Developments

Table 69. F Hoffman La Roche Details, Company Type, Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Area Served and Its Competitors

Table 70. F Hoffman La Roche Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product Offered

Table 71. F Hoffman La Roche Main Business

Table 72. F Hoffman La Roche Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 73. F Hoffman La Roche Latest Developments

Table 74. Foundation Medicine Details, Company Type, Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Area Served and Its Competitors

Table 75. Foundation Medicine Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product Offered

Table 76. Foundation Medicine Main Business

Table 77. Foundation Medicine Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 78. Foundation Medicine Latest Developments

Table 79. Thermo Fisher Scientific Inc. Details, Company Type, Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Area Served and Its Competitors

Table 80. Thermo Fisher Scientific Inc. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product Offered

Table 81. Thermo Fisher Scientific Inc. Main Business

Table 82. Thermo Fisher Scientific Inc. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 83. Thermo Fisher Scientific Inc. Latest Developments

Table 84. Leica Biosystems Nussloch GmBH Details, Company Type, Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Area Served and Its Competitors

Table 85. Leica Biosystems Nussloch GmBH Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product Offered

Table 86. Leica Biosystems Nussloch GmBH Main Business

Table 87. Leica Biosystems Nussloch GmBH Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 88. Leica Biosystems Nussloch GmBH Latest Developments

Table 89. Pfizer Details, Company Type, Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Area Served and Its Competitors

Table 90. Pfizer Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product Offered

Table 91. Pfizer Main Business

Table 92. Pfizer Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 93. Pfizer Latest Developments

List of Figures

Figure 1. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Type in 2021

Figure 7. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) in Oncology

Figure 8. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market: Oncology (2017-2022) & ($ Millions)

Figure 9. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) in Neurological Disorders

Figure 10. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market: Neurological Disorders (2017-2022) & ($ Millions)

Figure 11. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) in Cardiovascular Disease

Figure 12. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market: Cardiovascular Disease (2017-2022) & ($ Millions)

Figure 13. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) in Immunological Disorders

Figure 14. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market: Immunological Disorders (2017-2022) & ($ Millions)

Figure 15. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) in Others

Figure 16. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market: Others (2017-2022) & ($ Millions)

Figure 17. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Application in 2021

Figure 18. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Market Share by Player in 2021

Figure 19. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Regions (2017-2022)

Figure 20. Americas Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size 2017-2022 ($ Millions)

Figure 21. APAC Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size 2017-2022 ($ Millions)

Figure 22. Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size 2017-2022 ($ Millions)

Figure 23. Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size 2017-2022 ($ Millions)

Figure 24. Americas Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Value Market Share by Country in 2021

Figure 25. Americas Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Consumption Market Share by Type in 2021

Figure 26. Americas Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Application in 2021

Figure 27. United States Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth 2017-2022 ($ Millions)

Figure 28. Canada Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth 2017-2022 ($ Millions)

Figure 29. Mexico Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth 2017-2022 ($ Millions)

Figure 30. Brazil Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth 2017-2022 ($ Millions)

Figure 31. APAC Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Region in 2021

Figure 32. APAC Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Application in 2021

Figure 33. China Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth 2017-2022 ($ Millions)

Figure 34. Japan Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth 2017-2022 ($ Millions)

Figure 35. Korea Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth 2017-2022 ($ Millions)

Figure 36. Southeast Asia Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth 2017-2022 ($ Millions)

Figure 37. India Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth 2017-2022 ($ Millions)

Figure 38. Australia Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth 2017-2022 ($ Millions)

Figure 39. Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Country in 2021

Figure 40. Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Type in 2021

Figure 41. Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Application in 2021

Figure 42. Germany Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth 2017-2022 ($ Millions)

Figure 43. France Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth 2017-2022 ($ Millions)

Figure 44. UK Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth 2017-2022 ($ Millions)

Figure 45. Italy Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth 2017-2022 ($ Millions)

Figure 46. Russia Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth 2017-2022 ($ Millions)

Figure 47. Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Region in 2021

Figure 48. Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Type in 2021

Figure 49. Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Application in 2021

Figure 50. Egypt Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth 2017-2022 ($ Millions)

Figure 51. South Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth 2017-2022 ($ Millions)

Figure 52. Israel Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth 2017-2022 ($ Millions)

Figure 53. Turkey Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth 2017-2022 ($ Millions)

Figure 54. GCC Country Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth 2017-2022 ($ Millions)

Figure 55. Americas Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size 2023-2028 ($ Millions)

Figure 56. APAC Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size 2023-2028 ($ Millions)

Figure 57. Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size 2023-2028 ($ Millions)

Figure 58. Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size 2023-2028 ($ Millions)

Figure 59. United States Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size 2023-2028 ($ Millions)

Figure 60. Canada Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size 2023-2028 ($ Millions)

Figure 61. Mexico Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size 2023-2028 ($ Millions)

Figure 62. Brazil Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size 2023-2028 ($ Millions)

Figure 63. China Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size 2023-2028 ($ Millions)

Figure 64. Japan Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size 2023-2028 ($ Millions)

Figure 65. Korea Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size 2023-2028 ($ Millions)

Figure 66. Southeast Asia Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size 2023-2028 ($ Millions)

Figure 67. India Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size 2023-2028 ($ Millions)

Figure 68. Australia Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size 2023-2028 ($ Millions)

Figure 69. Germany Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size 2023-2028 ($ Millions)

Figure 70. France Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size 2023-2028 ($ Millions)

Figure 71. UK Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size 2023-2028 ($ Millions)

Figure 72. Italy Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size 2023-2028 ($ Millions)

Figure 73. Russia Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size 2023-2028 ($ Millions)

Figure 74. Spain Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size 2023-2028 ($ Millions)

Figure 75. Egypt Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size 2023-2028 ($ Millions)

Figure 76. South Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size 2023-2028 ($ Millions)

Figure 77. Israel Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size 2023-2028 ($ Millions)

Figure 78. Turkey Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size 2023-2028 ($ Millions)

Figure 79. GCC Countries Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size 2023-2028 ($ Millions)